Hims & Hers Health Inc (NYSE: HIMS) Could See Prices Soar In The Coming Months

Best AI Stocks

In the last trading session, 41.85 million shares of the Hims & Hers Health Inc (NYSE:HIMS) were traded, and its beta was 2.10. Most recently the company’s share price was $59.78, and it changed around $4.3 or 7.75% from the last close, which brings the market valuation of the company to $13.38B. HIMS currently trades at a discount to its 52-week high of $72.98, offering almost -22.08% off that amount. The share price’s 52-week low was $13.47, which indicates that the current value has risen by an impressive 77.47% since then.

Hims & Hers Health Inc stock received a consensus recommendation rating of Hold, based on a mean score of 2.50. If we narrow it down even further, the data shows that 1 out of 13 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 6 recommended HIMS as a Hold, whereas 4 deemed it a Buy, and 1 rated it as Underweight.

Hims & Hers Health Inc (NYSE:HIMS) trade information

Instantly HIMS has showed a green trend with a performance of 7.75% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 61.67 on recent trading dayincreased the stock’s daily price by 3.06%. The company’s shares are currently up 147.23% year-to-date, but still up 5.14% over the last five days. On the other hand, Hims & Hers Health Inc (NYSE:HIMS) is 2.05% up in the 30-day period.

The consensus price target as assigned by Wall Street analysts is $66.5, which translates to bulls needing to increase their stock price by 10.11% from its current value. Analyst projections state that HIMS is forecast to be at a low of $65 and a high of $68.

Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 17.22%. Hims & Hers Health Inc earnings are expected to increase by 27.49% in 2025, but the outlook is positive 34.58% per year for the next five years.

HIMS Dividends

Hims & Hers Health Inc’s next quarterly earnings report is expected to be released in July.

BLACKROCK INC., with 6.7907% or 14.57 million shares worth $294.25 million as of 2024-06-30, holds the second largest percentage of outstanding shares.

Marketing Sentinel
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.